Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kristina M Havas"'
Autor:
Gururaj Rao Kidiyoor, Qingsen Li, Giulia Bastianello, Christopher Bruhn, Irene Giovannetti, Adhil Mohamood, Galina V. Beznoussenko, Alexandre Mironov, Matthew Raab, Matthieu Piel, Umberto Restuccia, Vittoria Matafora, Angela Bachi, Sara Barozzi, Dario Parazzoli, Emanuela Frittoli, Andrea Palamidessi, Tito Panciera, Stefano Piccolo, Giorgio Scita, Paolo Maiuri, Kristina M. Havas, Zhong-Wei Zhou, Amit Kumar, Jiri Bartek, Zhao-Qi Wang, Marco Foiani
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
The nucleus is a mechanically stiff organelle of the cell and the DNA damage response protein ATR can localize to the nuclear envelope upon mechanical stress. Here, the authors show that ATR may contribute to the integrity of the nuclear envelope and
Externí odkaz:
https://doaj.org/article/ef3b7523ea5c4ef99f9147b73d2702d2
Autor:
Saverio Alberti, Laura Antolini, Nicola Tinari, Manuela Iezzi, Pietro Roversi, Massimo Pedriali, Patrizia Querzoli, Nicole Travali, Pasquale Simeone, Kristina M. Havas, Andrea Sacchetti, Ludovica Pantalone, Khouloud Boujnah, Martina Ceci, Romina Tripaldi, Rossano Lattanzio, Valeria Relli, Marco Trerotola, Emanuela Guerra
Supplementary Movie S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38280e45a49e7f825ba244207ef8ac88
https://doi.org/10.1158/1535-7163.22932210.v1
https://doi.org/10.1158/1535-7163.22932210.v1
Autor:
Saverio Alberti, Laura Antolini, Nicola Tinari, Manuela Iezzi, Pietro Roversi, Massimo Pedriali, Patrizia Querzoli, Nicole Travali, Pasquale Simeone, Kristina M. Havas, Andrea Sacchetti, Ludovica Pantalone, Khouloud Boujnah, Martina Ceci, Romina Tripaldi, Rossano Lattanzio, Valeria Relli, Marco Trerotola, Emanuela Guerra
Next-generation Trop-2–targeted therapy against advanced cancers is hampered by expression of Trop-2 in normal tissues. We discovered that Trop-2 undergoes proteolytic activation by ADAM10 in cancer cells, leading to the exposure of a previously in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::643e3a47b8127482baa4b306ef223703
https://doi.org/10.1158/1535-7163.c.6653601
https://doi.org/10.1158/1535-7163.c.6653601
Autor:
Saverio Alberti, Laura Antolini, Nicola Tinari, Manuela Iezzi, Pietro Roversi, Massimo Pedriali, Patrizia Querzoli, Nicole Travali, Pasquale Simeone, Kristina M. Havas, Andrea Sacchetti, Ludovica Pantalone, Khouloud Boujnah, Martina Ceci, Romina Tripaldi, Rossano Lattanzio, Valeria Relli, Marco Trerotola, Emanuela Guerra
Supplementary Online Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473942790b960d10ca590d123f786319
https://doi.org/10.1158/1535-7163.22932207.v1
https://doi.org/10.1158/1535-7163.22932207.v1
Autor:
Emanuela Guerra, Marco Trerotola, Valeria Relli, Rossano Lattanzio, Romina Tripaldi, Martina Ceci, Khouloud Boujnah, Ludovica Pantalone, Andrea Sacchetti, Kristina M. Havas, Pasquale Simeone, Nicole Travali, Patrizia Querzoli, Massimo Pedriali, Pietro Roversi, Manuela Iezzi, Nicola Tinari, Laura Antolini, Saverio Alberti
Next-generation Trop-2–targeted therapy against advanced cancers is hampered by expression of Trop-2 in normal tissues. We discovered that Trop-2 undergoes proteolytic activation by ADAM10 in cancer cells, leading to the exposure of a previously in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4edc1bcbc4ea474f57a82e66a82adb
https://hdl.handle.net/10281/425958
https://hdl.handle.net/10281/425958
Autor:
Kiran Raosaheb Patil, Martin Jechlinger, Kristina M. Havas, Andreas Schneeweiss, Jens Stolte, Toby J. Gibson, Marta Garcia, Eleni Kafkia, Giancarlo Pruneri, Vladislava Milchevskaya, Ksenija Radic, Rocio Sotillo, Barbara Burwinkel, Nicole Rotmensz, Bernd Klaus, Ashna Alladin
Publikováno v:
Journal of Clinical Investigation. 127:2091-2105
Tumor recurrence is the leading cause of breast cancer-related death. Recurrences are largely driven by cancer cells that survive therapeutic intervention. This poorly understood population is referred to as minimal residual disease. Here, using mous
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1, p 87 (2019)
Journal of Clinical Medicine; Volume 9; Issue 1; Pages: 87
Journal of Clinical Medicine, Vol 9, Iss 1, p 87 (2019)
Journal of Clinical Medicine; Volume 9; Issue 1; Pages: 87
Tumor recurrence is now the leading cause of breast cancer-related death. These recurrences are believed to arise from residual cancer stem cells that survive initial therapeutic intervention. Therefore, a comprehensive understanding of cancer stem c
Autor:
Mauro Angeletti, Melania Capitani, Maria Giovanna Sabbieti, Antonio Concetti, Nikolai Petrovsky, Franco M. Venanzi, Kristina M. Havas, Fadi Saade, Fabio Concetti, Dimitrios Agas
Publikováno v:
Current Gene Therapy. 14:161-169
Background: DNA vaccines provide high tolerability and safety but commonly suffer from suboptimal immunogenicity. We previously reported that a plasmid vector (pATRex), encoding the DNA sequence for the von Willebrand I/A domain of the tumor endothel
Autor:
Nathalie Rouleau, Tom Owen-Hughes, Anu-Maarit Moilanen, Zhigang Kang, Olli A. Jänne, Kristina M. Havas, Jorma J. Palvimo, Mati Reeben, Andrii Domanskyi
Publikováno v:
Molecular Biology of the Cell. 13:2106-2119
Nuclear receptors, including the androgen receptor (AR), regulate target cell transcription through interaction with auxiliary proteins to modify chromatin structure. We describe herein a novel AR-interacting protein, termed ARIP4, that has structura
Autor:
Michael L. Phelan, Robert E. Kingston, Kristina M. Havas, Paul A. Wade, Tom Owen-Hughes, David M.J. Lilley, Andrew Flaus
Publikováno v:
Cell. 103(7):1133-1142
ATP-dependent chromatin remodeling activities participate in the alteration of chromatin structure during gene regulation. All have DNA- or chromatin-stimulated ATPase activity and many can alter the structure of chromatin; however, the means by whic